Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLitigation Cap. Regulatory News (LIT)

Share Price Information for Litigation Cap. (LIT)

Share Price is delayed by 15 minutes
Get Live Data
2.60    -0.10 (-3.70%)
Bid:
2.50
Ask:
2.60
Spread: 0.10 (4.00%)
Market Cap: £2.68m
LIT Live PriceLast checked at - London Stock Exchange

Intraday Litigation Cap. Share Chart

Board Updates

2 Jul 2020 10:42

RNS Number : 8591R
Litigation Capital Management Ltd
02 July 2020
Β 

2 July 2020

Β 

Litigation Capital Management Limited

(LCM or the Company)

Β 

Board Updates

Β 

Litigation Capital Management Limited (AIM:LIT), specialist alternate asset manager and a leading international provider of disputes financing solutions, provides the following update:

Β 

Β· LCM currently looking to expand the geographic market reach of its Non-Executive Directors in line with LCM's business plan

Β· Steve McLean steps down as non-executive director as part of this upcoming Board realignment

Β· Minor delays in the CEO relocating to London due to COVID-19

Β 

LCM is at an advanced stage in the search to add additional Non-Executive Directors (NED) to the Board. As the Company strengthens its market positioning in the Northern Hemisphere, including the UK and Europe, as well as transitioning its management to the London office, it looks to new NED appointments to bring significant experience in these markets. As part of this upcoming restructuring, SteveΒ McLean has kindly agreed to resign his position on the board effective as at 30 June 2020.

Β 

Steve was appointed to LCM's board as a NED prior to the Company's IPO on the Australian Securities Exchange. Steve brought with him significant in-region equity capital markets experience and has been a very valuable member of LCM's board during the building of its business, particularly in the APAC region.

Β 

LCM expects to be in a position to make an announcement as to a new Non-Executive board member in the near future.

Β 

Jonathan Moulds, Chairman of LCM, commented: "Steve has been a strong supporter of LCM through two IPOs, one on the Australian Securities Exchange and then on the London Stock Exchange:AIM as a Non-Executive board member. As LCM's business expands into new global markets, it will benefit from board experience in those large economies. We will continue to have access to Steve and his experience was a long-term supporter of the business. I thank him for his significant contribution to the growth of LCM over a number of years"

Β 

Enquiries

Β 

Litigation Capital Management

c/o Alma PRΒ 

Patrick Moloney, Chief Executive Officer

Β 

Β 

Β 

Canaccord (Nomad and Joint Broker)Β 

Tel: 020 7523 8000

Bobbie Hilliam

Β 

Β 

Β 

Investec Bank plc (Joint Broker)

Tel: 020 7597 5970

David Anderson

Β 

Β 

Β 

Alma PR

Tel:Β 020 3405 0205

Rebecca Sanders-Hewett

LCM@almapr.co.uk

Justine James

Β 

David Ison

Β 

Β 

NOTES TO EDITORS

Β 

Litigation Capital Management (LCM) is a global provider of disputes finance which operates two business models. The first is direct investments made from LCM's permanent balance sheet capital and the second is fund and/or asset management. Under those two business models, LCM currently pursues three investment strategies: Single-case funding, Corporate portfolio funding and Acquisitions of claims. LCM generates its revenue from both its direct investments and also performance fees through asset management.

LCM has an unparalleled track record, driven by effective project selection, active project management and robust risk management.

Β 

Headquartered in Sydney, with offices in London, Singapore, Brisbane and Melbourne, LCM listed on AIM in December 2018, trading under the ticker LIT.

Β 

www.lcmfinance.com

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
Β 
END
Β 
Β 
BOASSUSUEESSEDW
Date   Source Headline
31st Oct 20247:00 amRNSTransaction in Own Shares
30th Oct 20247:00 amRNSExercise of Awards
30th Oct 20247:00 amRNSTransaction in Own Shares
29th Oct 20247:00 amRNSTransaction in Own Shares
28th Oct 20247:00 amRNSTransaction in Own Shares
25th Oct 20247:00 amRNSTransaction in Own Shares
24th Oct 20247:00 amRNSTransaction in Own Shares
23rd Oct 20247:00 amRNSTransaction in Own Shares
22nd Oct 20247:00 amRNSTransaction in Own Shares
21st Oct 20247:00 amRNSExercise of Awards
18th Oct 20247:00 amRNSTransaction in Own Shares
15th Oct 20247:01 amRNSTransaction in Own Shares
15th Oct 20247:00 amRNSChange of Nominated Adviser and Broker
14th Oct 20247:00 amRNSTransaction in Own Shares
9th Oct 202411:32 amRNSResult of AGM
9th Oct 20247:00 amRNSTransaction in Own Shares
8th Oct 202411:55 amRNSPositive update on Fund I investment
8th Oct 20247:00 amRNSTransaction in Own Shares
7th Oct 20247:00 amRNSTransaction in Own Shares
4th Oct 20247:00 amRNSTransaction in Own Shares
3rd Oct 20247:00 amRNSTransaction in Own Shares
2nd Oct 20247:00 amRNSTransaction in Own Shares
1st Oct 20247:00 amRNSTransaction in Own Shares
27th Sep 20247:01 amRNSTransaction in Own Shares
27th Sep 20247:00 amRNSDividend currency entitlement
25th Sep 20247:00 amRNSTransaction in Own Shares
24th Sep 20247:00 amRNSTransaction in Own Shares
20th Sep 20247:00 amRNSTransaction in Own Shares
19th Sep 20247:00 amRNSTransaction in Own Shares
18th Sep 20247:00 amRNSTransaction in Own Shares
17th Sep 20246:05 pmRNSDividend Date
17th Sep 20245:20 pmRNSNotice of AGM
17th Sep 20247:01 amRNSTransaction in Own Shares
17th Sep 20247:00 amRNSFull year audited results for the YE 30 June 2024
13th Sep 20247:00 amRNSTransaction in Own Shares
11th Sep 20247:00 amRNSTransaction in Own Shares
10th Sep 20247:00 amRNSTransaction in Own Shares
9th Sep 20247:00 amRNSTransaction in Own Shares
6th Sep 20247:00 amRNSTransaction in Own Shares
5th Sep 20242:25 pmRNSResignation of Director
5th Sep 20247:00 amRNSTransaction in Own Shares
4th Sep 20247:00 amRNSTransaction in Own Shares
3rd Sep 20247:00 amRNSTransaction in Own Shares
30th Aug 20247:00 amRNSTransaction in Own Shares
29th Aug 20247:00 amRNSTransaction in Own Shares
28th Aug 20247:00 amRNSTransaction in Own Shares
23rd Aug 20247:00 amRNSTransaction in Own Shares
22nd Aug 20247:00 amRNSTransaction in Own Shares
21st Aug 20247:00 amRNSTransaction in Own Shares
20th Aug 20247:01 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.